4//SEC Filing
Hom Dennis 4
Accession 0001104659-23-082724
CIK 0001400118other
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 4:16 PM ET
Size
16.7 KB
Accession
0001104659-23-082724
Insider Transaction Report
Form 4
Hom Dennis
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-07-18+9,286→ 9,286 totalExercise: $6.36Exp: 2029-04-27→ Series A Common Stock (9,286 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-07-18−136,846→ 0 totalExercise: $6.36Exp: 2031-01-26→ Common Stock (136,846 underlying) - Award
Stock Option (Right to Buy)
2023-07-18+111,438→ 111,438 totalExercise: $6.36Exp: 2029-04-27→ Series A Common Stock (111,438 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-07-18−9,286→ 0 totalExercise: $6.36Exp: 2029-04-27→ Common Stock (9,286 underlying) - Award
Stock Option (Right to Buy)
2023-07-18+136,846→ 136,846 totalExercise: $6.36Exp: 2031-01-26→ Series A Common Stock (136,846 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-07-18−111,438→ 0 totalExercise: $6.36Exp: 2029-04-27→ Common Stock (111,438 underlying)
Footnotes (3)
- [F1]Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.
- [F2]The shares underlying this option are fully vested and exercisable as of the date hereof.
- [F3]The shares underlying this option shall vest in forty-eight (48) equal monthly installments following January 27, 2021, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Sagimet Biosciences Inc.
CIK 0001400118
Entity typeother
Related Parties
1- filerCIK 0001600362
Filing Metadata
- Form type
- 4
- Filed
- Jul 19, 8:00 PM ET
- Accepted
- Jul 20, 4:16 PM ET
- Size
- 16.7 KB